These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 5555409

  • 1. The ABO blood groups and results of therapeutic oophorectomy for advanced carcinoma of the breast.
    Lee YT.
    Surg Gynecol Obstet; 1971 May; 132(5):871-5. PubMed ID: 5555409
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of prophylactic and therapeutic castration in breast carcinoma.
    Fracchia AA, Murray DR, Farrow JH, Balachandra VK.
    Surg Gynecol Obstet; 1969 Aug; 129(2):270-6. PubMed ID: 5794401
    [No Abstract] [Full Text] [Related]

  • 3. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy.
    Harvey JC, Rosen PP, Ashikari R, Robbins GF, Kinne DW.
    Surg Gynecol Obstet; 1981 Nov; 153(5):723-5. PubMed ID: 7292273
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Local recurrences of carcinoma of the breast.
    Marshall KA, Redfern A, Cady B.
    Surg Gynecol Obstet; 1974 Sep; 139(3):406-8. PubMed ID: 4853027
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Results of a clinical trial concerning the worth of prophylactic oophorectomy for breast carcinoma.
    Ravdin RG, Lewison EF, Slack NH, Dao TL, Gardner B, State D, Fisher B.
    Surg Gynecol Obstet; 1970 Dec; 131(6):1055-64. PubMed ID: 4991334
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
    Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM.
    Cancer; 2003 Aug 15; 98(4):697-702. PubMed ID: 12910512
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Skin-sparing mastectomy and immediate reconstruction is an acceptable treatment option for patients with high-risk breast carcinoma.
    Downes KJ, Glatt BS, Kanchwala SK, Mick R, Fraker DL, Fox KR, Solin LJ, Bucky LP, Czerniecki BJ.
    Cancer; 2005 Mar 01; 103(5):906-13. PubMed ID: 15651068
    [Abstract] [Full Text] [Related]

  • 20. Is axillary lymph node dissection necessary in routine management of breast cancer? No.
    Cady B.
    Important Adv Oncol; 1996 Mar 01; ():251-65. PubMed ID: 8791141
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.